Going forward: Increasing the accessibility of imaging mass spectrometry

Area of Science:

• Biomedical imaging
• Analytical chemistry
• Molecular pathology

Background:

• Imaging mass spectrometry (MS) is increasingly popular for biomarker discovery and pharmaceutical distribution analysis in tissues.
• Current MS imaging studies are often isolated, lacking standardized methods and collaborative data sharing.
• Existing tissue preparation, data acquisition, and analysis techniques vary widely across laboratories.

Purpose of the Study:

• To address the need for standardized methods in molecular histology and pharmaceutical development using MS imaging.
• To increase the accessibility and collaborative potential of MS imaging for the broader scientific community.
• To establish best practice guidelines for MS imaging through international collaboration.

Main Methods:

• Formation of a new European imaging MS network.
• Explicit comparison and contrast of existing MS imaging methods.
• Development of a collaborative framework for methodological exchange and data sharing.

Main Results:

• Initiation of a network focused on comparing and contrasting diverse MS imaging techniques.
• Activities centered on developing standardized protocols and best practice guidelines.
• Facilitation of methodological exchange and synergistic exploration of analytical capabilities.

Conclusions:

• Standardized methods are crucial for advancing MS-based molecular histology and pharmaceutical assays.
• A collaborative European network will enhance the accessibility and comparability of MS imaging techniques.
• The network's activities will lead to robust, standardized methods benefiting the healthcare research community.